Cargando…
Natural Killer Cells in Immunotherapy: Are We Nearly There?
SIMPLE SUMMARY: Here, we review the last pre-clinical and clinical studies published in the last five years where natural killer (NK) cells have been administered as an immunotherapy option for the treatment of cancer patients. We describe studies administering NK cells alone and in combination with...
Autores principales: | Bachiller, Mireia, Battram, Anthony M., Perez-Amill, Lorena, Martín-Antonio, Beatriz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694052/ https://www.ncbi.nlm.nih.gov/pubmed/33120910 http://dx.doi.org/10.3390/cancers12113139 |
Ejemplares similares
-
Natural Killer Cells: Angels and Devils for Immunotherapy
por: Martín-Antonio, Beatriz, et al.
Publicado: (2017) -
Senescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword
por: Battram, Anthony M., et al.
Publicado: (2020) -
NK cells enhance CAR-T cell antitumor efficacy by enhancing immune/tumor cells cluster formation and improving CAR-T cell fitness
por: Bachiller, Mireia, et al.
Publicado: (2021) -
Natural killer cell immunotherapy in glioblastoma
por: Hosseinalizadeh, Hamed, et al.
Publicado: (2022) -
Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
por: Iyoda, Tomonori, et al.
Publicado: (2023)